Alphamab Oncology (9966.HK)

HKD 7.85

(21.52%)

Total Debt Summary of Alphamab Oncology

Alphamab Oncology's latest annual total debt in 2023 was 257.08 Million CNY , down -25.57% from previous year.
Alphamab Oncology's latest quarterly total debt in 2024 Q2 was 320 Million CNY , down 0.0% from previous quarter.
Alphamab Oncology reported annual total debt of 345.39 Million CNY in 2022, down -45.8% from previous year.
Alphamab Oncology reported annual total debt of 637.27 Million CNY in 2021, up 186.02% from previous year.
Alphamab Oncology reported quarterly total debt of 257.08 Million CNY for 2023 Q4, down 0.0% from previous quarter.
Alphamab Oncology reported quarterly total debt of 257.08 Million CNY for 2023 FY, down -25.57% from previous quarter.

Annual Total Debt Chart of Alphamab Oncology (2023 - 2017)

Historical Annual Total Debt of Alphamab Oncology (2023 - 2017)

Year	Total Debt	Total Debt Growth
2023	257.08 Million CNY	-25.57%
2022	345.39 Million CNY	-45.8%
2021	637.27 Million CNY	186.02%
2020	222.8 Million CNY	-12.0%
2019	253.17 Million CNY	128.05%
2018	111.02 Million CNY	5428.88%
2017	2 Million CNY	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	320 Million CNY	0.0%
2023 Q4	257.08 Million CNY	0.0%
2023 FY	257.08 Million CNY	-25.57%
2023 Q2	283.58 Million CNY	0.0%
2022 Q2	526.09 Million CNY	0.0%
2022 FY	345.39 Million CNY	-45.8%
2022 Q4	345.39 Million CNY	0.0%
2021 Q2	313.19 Million CNY	0.0%
2021 Q4	637.27 Million CNY	0.0%
2021 FY	637.27 Million CNY	186.02%
2020 Q2	249.66 Million CNY	0.0%
2020 FY	222.8 Million CNY	-12.0%
2020 Q4	222.8 Million CNY	0.0%
2019 FY	253.17 Million CNY	128.05%
2019 Q4	253.17 Million CNY	0.0%
2019 Q2	176.37 Million CNY	0.0%
2018 Q4	111.02 Million CNY	0.0%
2018 FY	111.02 Million CNY	5428.88%
2017 FY	2 Million CNY	0.0%

Peer Total Debt Comparison of Alphamab Oncology

Name	Total Debt	Total Debt Difference
Uni-Bio Science Group Limited	52.86 Million HKD	-386.277%
CK Life Sciences Int'l., (Holdings) Inc.	5.93 Billion HKD	95.666%